S1PR1, S1PR2 and S1PR3 were shown to be elevated in patient brain-tumor samples compared to normal brain samples, and Kaplan–Meier analyses have demonstrated an association between S1PR1 and S1PR2 with patients’ survival times [15]. This evidence concerns the gene S1PR2 and brain neoplasm.